Companies
Medical / Health Care
Medical Monitoring
RTI Group AB

ALL Chemistry Inc. -Model SJAK10613 -JAK2 inhibitor G5-7

JAK2 inhibitor G5-7 is an orally active JAK2 inhibitor, selectively inhibits JAK2–mediated phosphorylation and activation of EGFR (Tyr1068) and STAT3 by binding to JAK2. G5-7 has the potential for glioma study.